In 2023, the sold production of medicaments containing vitamins, provitamins, derivatives, and intermixtures thereof in France was valued at 107..Between 2024 and 2028, the market is forecasted to experience a sharp decline of approximately 47% during this period, as it decreases from 97.094 million Euros to 56.699 million Euros by 2028. The annual average rate of decrease, or CAGR, over these years is approximately -10.18%.
Future trends to watch for include:
- Potential shifts in consumer preferences towards alternative health supplements.
- The impact of regulatory changes on product formulations or marketing.
- Technological advancements that could alter production efficiencies or costs.
